Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Research Funding topic
No spam. Unsubscribe anytime.
LSU leaders warn committee of federal grant uncertainty, urge state backing for Pennington and research capacity
Summary
University leaders told the Senate Finance Committee that research activity is growing but federal grant uncertainty — including potential changes to indirect cost reimbursements — could reduce research revenue and that Pennington Biomedical needs state attention to preserve momentum.
LSU and affiliated research leaders told the Senate Finance Committee on April 7 that research activity in Louisiana has strengthened but also flagged federal funding uncertainty that could reduce reimbursements that many institutions rely on to support research infrastructure.
Dr. William Tate, president of the LSU System, said total research activity across LSU approached half a billion dollars and was growing year over year. He described aims to position LSU in the top 50 research universities nationally and outlined recent grant wins and ambitions, including coastal resilience efforts and a planned large NSF engine application.
Tate and other witnesses highlighted Pennington Biomedical Research Center’s reliance on federal grant flows and cautioned that proposed federal changes — for example to indirect cost rates or general grant availability — could have direct financial impact. Tate said an indirect cost policy change proposed at the federal level could have meant a $12 million reduction to LSU in one estimate if it had been implemented as initially described.
Senators pressed the LSU delegation about short‑term impacts and asked whether state contingency funding would be needed to sustain research labs and recruitment if federal flows decline. Tate and Pennington representatives said federal funding remains the main revenue source for research; they urged the legislature to consider state support where federal risks could threaten highly leveraged research facilities that have economic and public‑health value for Louisiana.
Committee members asked for follow‑up materials, including specific Pennington needs and costed scenarios should federal grant support decline. No formal votes were taken.
